National Cancer Institute NCI Cancer Bulletin: A Trusted Source for Cancer Research News
November 3, 2009 • Volume 6 / Number 21

The information and links on this page are no longer being updated and are provided for reference purposes only.

NEWS

To make progress in treating pancreatic cancer, scientists need a better understanding of the complex signaling pathways in pancreatic tumors and new animal models. Pancreatic Cancer Report Urges Changes in Clinical Trials

The slow but steady march toward more individualized care in cancer medicine has left pancreatic cancer behind. Patients diagnosed with this disease live no longer today than patients diagnosed 2 decades ago, despite more than a dozen large clinical trials. Even as many patients with other cancers have benefited from targeted drugs like imatinib (Gleevec) and trastuzumab (Herceptin), pancreatic cancer remains as deadly as ever. Read more > >

COMMENTARY

Dr. Cathy Backinger

Guest Director's Update: Entering a New Era in Tobacco Control Research

by Dr. Cathy Backinger

With the enactment of the Family Smoking Prevention and Tobacco Control Act on June 22, the United States entered a new era in tobacco control and prevention. While the importance of the new law cannot be overstated, it is only one component of a much larger, comprehensive tobacco control and prevention agenda, for which NCI-supported science is critically important. This issue of the NCI Cancer Bulletin highlights several important tobacco control research studies supported by NCI.

Read more > >

IN DEPTH

UPDATES

  • Cancer.gov Update

    • Adolescent and Young Adult Cancer Portal Launched
    • A New Face for Smokefree.gov

    Notes

    • NCI Launches Physical Sciences-Oncology Centers
    • Spanish Clinical Trials Promotional Tools Available from NCI
    • Meet NCI Experts at APHA

The NCI Cancer Bulletin is produced by the National Cancer Institute (NCI), which was established in 1937. Through basic, clinical, and population-based biomedical research and training, NCI conducts and supports research that will lead to a future in which we can identify the environmental and genetic causes of cancer, prevent cancer before it starts, identify cancers that do develop at the earliest stage, eliminate cancers through innovative treatment interventions, and biologically control those cancers that we cannot eliminate so they become manageable, chronic diseases.

For more information about cancer, call 1-800-4-CANCER or visit http://www.cancer.gov.

NCI Cancer Bulletin staff can be reached at ncicancerbulletin@mail.nih.gov.

Next Section >